Citations

Clear

32 citation(s) found for "Eldrige, Jason".

Pain medicine fellow neuromodulation surgical skill assessment tool: a pilot
Pittelkow, Thomas P. , Hagedorn, Jonathan M. , Bendel, Markus A. , Eldrige, Jason S. , Pingree, Matthew J. , Mauck, William D. , Gazelka, Halena M. , Lamer, Tim J. , Sanders, Rebecca A., Billinges, Heather A, Moeschler, Susan M. , Billings, Heather , Mauck, W David, Pittelkow, Thomas P , Hagedorn, Jonathan M , Billings, Heather

Mayo Clinic

Regional Anesthesia & Pain Medicine | November 6, 2019 | Volume: 45 | Issue: 1 | Pages: 38-43

10.1136/rapm-2019-100761 | PMID 31694935 Get It

Objective Spinal cord stimulation (SCS) is an evidence-based therapy for the treatment of refractory pain. Current American College of Graduate Medical Education requirements for pain medicine fellowship graduation include observation of five neuromodulation cases. Matriculating fellows have varying degrees of technical skill, training, and experience. The purpose of this study was to use an innovative skill-based assessment tool using the validated Zwisch scale to evaluate fellow surgical performance during SCS cases. Design Cross-sectional survey Setting Mayo Clinic, Rochester, Minnesota. Subjects Consultant faculty (10) in the Division of Pain Medicine and pain medicine fellows (5). Methods A list of faculty-driven neuromodulation surgical objectives was formed and a rubric was created that focused on technical approach, imaging, epidural access and wound closure. Consultants who perform surgical cases were instructed to use the Zwisch scale as a guide to evaluate fellow surgical performance during a neuromodulation case. Faculty and fellows were surveyed before and after implementation of the tool to determine their satisfaction with use of the skill assessment tool. Results The consultants reported they were more satisfied, consistent, and efficient with feedback provided to the trainee on every aspect of neuromodulation surgical cases. The improvement was most significant during the fellows’ intraoperative skill assessment. The fellows indicated increased satisfaction, improved communication, and increased efficiency of feedback when the tool was utilized. The fellows reported greater intraoperative skill assessment and consistency of feedback provided. Conclusions The diverse nature of primary specialty backgrounds observed in pain medicine fellowship training offers a unique opportunity to assess and improve fellow skill and surgical competence in the field of neuromodulation. Both faculty and fellows reported improved satisfaction, consistency and efficiency with feedback provided. Importantly, this pilot project observed that implementation of a skill assessment tool was beneficial for both the faculty and fellow as the feedback received was viewed as strongly beneficial to the educational experience.
Procedural predictors of epidural blood patch efficacy in spontaneous intracranial hypotension
Pagani-Estévez, Gabriel L., Cutsforth‐Gregory, Jeremy K. , Mokri, Bahram, Piepgras, David G., Mauck, William D. , Eldrige, Jason S. , Watson, James C. , Morris, Jonathan M.

Mayo Clinic

Regional Anesthesia & Pain Medicine | January 13, 2019 | Volume: 44 | Issue: 2 | Pages: 212-220

10.1136/rapm-2018-000021 | PMID 30636714 Get It

Background and objective Epidural blood patch (EBP) is a safe and effective treatment for spontaneous intracranial hypotension (SIH), but clinical and procedural variables that predict EBP efficacy remain nebulous. Methods This study is an institutional review board-approved retrospective case series with dichotomized EBP efficacy defined at 3 months. The study included 202 patients receiving 604 EBPs; iatrogenic cerebrospinal fluid leaks were excluded. Results Of the EBPs, 473 (78%) were single-level, 349 (58%) lumbar, 75 (12%) bilevel, and 56 (9%) multilevel (≥3 levels). Higher volume (OR 1.64; p<0.0001), bilevel (3.17, 1.91–5.27; p<0.0001), and multilevel (117.3, 28.04–490.67; p<0.0001) EBP strategies predicted greater efficacy. Only volume (1.64, 1.47–1.87; p<0.0001) remained significant in multivariate analysis. Site-directed patches were more effective than non-targeted patches (8.35, 0.97–72.1; p=0.033). Lower thoracic plus lumbar was the most successful bilevel strategy, lasting for a median of 74 (3–187) days. Conclusions In this large cohort of EBP in SIH, volume, number of spinal levels injected, and site-directed strategies significantly correlated with greater likelihood of first EBP efficacy. Volume and leak site coverage likely explain the increased efficacy with bilevel and multilevel patches. In patients with cryptogenic leak site, and either moderate disability, negative prognostic brain MRI findings for successful EBP, or failed previous lumbar EBP, a low thoracic plus lumbar bilevel EBP strategy is recommended. Multilevel EBP incorporating transforaminal administration and fibrin glue should be considered in patients refractory to bilevel EBP. An algorithmic approach to treating SIH is proposed.
Office-Based Mesenchymal Stem Cell Therapy for the Treatment of Musculoskeletal Disease: A Systematic Review of Recent Human Studies
Law, Luke, Wijnen, André J. van , Eldrige, Jason S. , Mauck, William D. , Pingree, Mathew J., Yang, Juan , Muir, Casey W, Erwin, Patricia J., Bydon, Mohamad , Qu, Wenchun , van Wijnen, Andre J , Hunt, Christine , Nassr, Ahmad , Larson, A. Noelle , Muir, Casey

Mayo Clinic

Pain Medicine | December 3, 2018 | Volume: 20 | Issue: 8 | Pages: 1570-1583

10.1093/pm/pny256 | PMID 30597057 Get It

Abstract Background The use of mesenchymal stem cells (MSCs) in clinical applications for the treatment of musculoskeletal disease is steadily increasing in office-based practice. The so-called “first generation” of MSCs is defined as autologous stem cells that have undergone minimal manipulation and are used for a homologous purpose. Systematic reviews of the clinical trials completed to date of such MSCs enable practitioners to better understand what is currently known about the outcomes and side effects of such treatments. Study Design A systematic review of human clinical studies of office-based MSC therapy for the treatment of painful degenerative musculoskeletal conditions. Methods A search of the Ovid MEDLINE, EMBASE, and Scopus databases was conducted from 2006 through September 2016. Seven hundred sixty-one records were identified from database searching, and two records from reference review of included papers. Studies with human subjects that evaluated treatment of musculoskeletal disease with minimally manipulated MSCs were included. Results Eight studies were included in this review based on selection criteria. A total of 941 patients were included, 841 of whom received cellular products, and no significant adverse events were reported. Symptomatology generally improved, though no differences were seen over controls where present. Conclusion Support in the literature is strongest for the use of bone marrow aspirate concentrate (BMAC) injections for the treatment of knee pain, but applications of the use of BMAC and peripheral blood–derived MSCs for the treatment of hip pain, tendon pain, and disc pain have all been reported. Further research is required, with large randomized controlled trials.
Opioids: Clinical Practice, Monitoring, and Medicolegal Considerations
Eldrige, Jason S. , Rho, Richard H., Martin, Joanne L., Murphy, Joshua B., Hooten, W. Michael

Mayo Clinic

The Journal of Applied Laboratory Medicine | July 23, 2018 | Volume: 2 | Issue: 4 | Pages: 573-586

10.1373/jalm.2017.024026 | PMID 33636882 Get It

Abstract Background In the past decade, opioid use in the general population of the US has increased dramatically. Concomitantly, opioid-related morbidity and mortality have also risen steeply. The causes of opioid over-prescribing are multifactorial, with pressure from medical agencies, patients, aggressive patient-directed marketing, and use of patient surveys as an evaluation tool to unduly influence medical providers' decision-making. Providers also have significant concerns regarding scrutiny from their medical board and exposure to medicolegal liability. Content To provide the basis for best practice recommendations, several aspects of modern opioid prescribing practice require review. The practicing clinician should be aware of: (a) the pervasiveness of current opioid prescribing within the US; (b) the availability and applicability of clinical tools used to assess patient risk; (c) the new guidelines designed to facilitate appropriate and safe medical use of opioids; (d) the incorporation of clinical tools and best documentation practices to reduce medicolegal exposure. Summary On completion of this review, the reader should be able to recognize the magnitude of the problem of opioid over-prescribing in the US and identify several patient risk factors for opioid misuse, abuse, and/or diversion. Specifically, better familiarity with the recently published CDC guidelines for opioid prescribing will help ensure the adoption of best-use practices that maximize therapeutic efficacy while attenuating the possibility of harm to patients. A thorough review of the legal principles and risk-mitigation strategies relevant to opioid prescribing will also lessen the clinician's exposure to medicolegal liability.
Dexmedetomidine as Part of a Multimodal Analgesic Treatment Regimen for Opioid Induced Hyperalgesia in a Patient with Significant Opioid Tolerance
Patch, Richard K. , Eldrige, Jason S. , Moeschler, Susan M. , Pingree, Matthew J. , Patch Iii, Richard K

Mayo Clinic

Case Reports in Anesthesiology | September 25, 2017 | Volume: 2017 | Issue: No issue available | Pages: 1-5

10.1155/2017/9876306 | PMID 29147587 Get It

Acute postoperative pain in patients with opioid tolerance creates a significant management challenge for anesthesiologists and pain medicine physicians. A multimodal approach is key; however other factors can complicate management such as opioid induced hyperalgesia. We present the case of a patient on large amounts of intrathecal opioids for chronic pain syndrome with opioid induced hyperalgesia after an exploratory laparotomy. Dexmedetomidine was utilized successfully as part of a controlled multimodal analgesic plan and should be a consideration for opioid tolerant patients experiencing opioid induced hyperalgesia.
Utilization of Leads After Permanent Implant in Spinal Cord Stimulator Systems
Sanders, Rebecca A., Hoelzer, Bryan C. , Bendel, Markus A. , Lamer, Tim J. , Eldrige, Jason S. , Pingree, Matthew J. , Moeschler, Susan M. , Gazelka, Halena M. , Mauck, William D. , Rho, Richard H., Mauck, W David, Pittelkow, Thomas P.

Mayo Clinic

Pain Practice | September 23, 2017 | Volume: 18 | Issue: 5 | Pages: 562-567

10.1111/papr.12644 | PMID 28941145 Get It

AbstractObjectiveThe goal of this study was to determine the frequency and clinical indications associated with implantation of single vs. dual percutaneous lead spinal cord stimulator (SCS) systems and to look further into how these leads are utilized for treatment.Materials and MethodsA retrospective cohort analysis of all patients undergoing SCS implantation between January 2001 and December 2013 with a minimum of 2 years of clinical follow‐up was performed. Number of trial leads and implanted leads was recorded. For patients with dual‐lead systems, it was noted if and when the second lead was used, along with the clinical indication for lead activation.ResultsIn the 259‐patient cohort, 15.8% (n = 41) patients underwent placement of a single‐lead system, 83.0% (n = 215) underwent placement of a dual‐lead system, and 1.2% (n = 3) underwent placement of 3‐lead systems. Placement of dual‐lead systems was similar among all indication groups. Of those patients with a dual‐lead system in place, 88.1% utilized both leads and average time to programming of the second lead was 2.3 months. The most common reason to activate the second lead was inadequate stimulation coverage. Five of the 41 patients with single‐lead systems underwent an additional surgery to implant a second lead due to inadequate stimulation with 1 lead.ConclusionsTo our knowledge this is the first descriptive analysis of the frequency of single‐ and dual‐lead SCS systems. This report indicates that dual‐lead systems are most often placed and both leads are required for optimal patient therapy.
Intercostal Nerve Blocks Using Liposomal Bupivacaine
Höfer, R , Rosenberg, Casandra, Niesen, Adam D. , Eldrige, Jason S. , Amundson, Adam W.

Mayo Clinic

Anaesthesia Cases | October 31, 2016 | Volume: 3 | Issue: 1 | Pages: 34-37

10.21466/ac.inbulb2.2015 Get It

SummaryA 51‐year‐old male was admitted to the intensive care unit following a cardiac arrest during which he received chest compressions and suffered rib fractures. The patient's condition subsequently improved and tracheal extubation was eventually planned. However, he was unable to tolerate spontaneous breathing trials due to pain from his rib fractures. Systemic analgesia provided either insufficient pain control or over‐sedation. Neuraxial techniques were contraindicated as he was receiving systemic anticoagulation and antiplatelet medications. Intercostal nerve blocks with liposomal bupivacaine were performed under ultrasound guidance without complications. Approximately six hours after the injections, the patients trachea was successfully extubated with no further need for respiratory support through to discharge. In appropriately selected patients, intercostal nerve blocks with liposomal bupivacaine can adequately treat pain from rib fractures and improve respiratory mechanics.
Regarding the Safety of Interventional Pain Procedures in the Setting of Anticoagulation
Moeschler, Susan M. , Eldrige, Jason S. , Warner, Nafisseh S.

Mayo Clinic

Pain Medicine | October 27, 2016 | Volume: 18 | Issue: 4 | Pages: 819-820

10.1093/pm/pnw253 | PMID 28034976 Get It

Treatment of Refractory Postdural Puncture Headache after Intrathecal Drug Delivery System Implantation with Epidural Blood Patch Procedures: A 20-Year Experience
Bendel, Markus A. , Moeschler, Susan M. , Qu, Wenchun , Hanley, Eugerie, Neuman, Stephanie, Eldrige, Jason S. , Hoelzer, Bryan C. , Neuman, Stephanie A

Mayo Clinic

Pain Research and Treatment | August 11, 2016 | Volume: 2016 | Issue: No issue available | Pages: 1-5

10.1155/2016/2134959 | PMID 27597897 Get It

A recent publication reported the incidence of postdural puncture headache (PDPH) in conjunction with intrathecal drug delivery system (IDDS) implantation to be nearly 23 percent. Many patients responded to conservative measures but a percentage needed invasive treatment with an epidural blood patch (EBP). There is limited data to describe the technical details, success rates, and complications associated with EBP in this population. This study aims to provide a retrospective report of EBP for patients suffering from PDPH related to IDDS implantation. A chart review established a cohort of patients that required EBP in relation to a PDPH after IDDS implantation. This cohort was evaluated for demographic data as well as details of the EBP including technical procedural data, success rates, and complications. All patients received a trial of conservative therapy. Standard sterile technique and skin preparation were utilized with no infectious complications. The EBP was placed below the level of the IDDS catheter in 94% of procedures. Fluoroscopy was utilized in each case. The mean EBP volume was 18.6 cc and median time of EBP was day 7 after implant. There were no complications associated with EBP. EBP appears to be an effective intervention in this subset of PDPH patients.
Improved perioperative analgesia with ultrasound-guided ilioinguinal/iliohypogastric nerve or transversus abdominis plane block for open inguinal surgery: a systematic review and meta-analysis of randomized controlled trials
Terry, Marisa J., Eldrige, Jason S. , Tong, Qiang , Erwin, Patricia J., Qu, Wenchun , Wang, Yuexiang, Wang, Yuexiang , Wu, Tao , Tong, Qiang, Wang, Zhen

Mayo Clinic

Journal of Physical Therapy Science | March 30, 2016 | Volume: 28 | Issue: 3 | Pages: 1055-1060

10.1589/jpts.28.1055 | PMID 27134411 Get It